Recent finishings have shown that IFN-β gene delivery could stimulate apoptosis in IFN-β-resistant cancer cells, such as, melanoma, glioma, and renal cell carcinoma (RCC) (85). The gene discussed is IFNB1; the disease is hereditary clear cell renal cell carcinoma.